Christopher Leamon, VP of Research at Endocyte, holds 11.96K shares in Fusion Pharmaceuticals (Ticker: FUSN), holds 0.00 shares in Endocyte (Ticker: ECYT).

See the Hottest Stocks Based on Insider Trading >

Christopher Leamon
Endocyte (ECYT)
VP of Research

Ranked #77,203 out of 98,743 Corporate Insiders

Profitable Transactions

0 out of 2 Profitable Transactions

Average Return

-37.50%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

100.00%

FUSN

A breakdown of Christopher Leamon's holdings

See the Top Stocks by Insiders

Insider Roles

Fusion Pharmaceuticals
(FUSN)

CSO

Roles that Christopher Leamon holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Endocyte
(ECYT)

Rating:Informative Buy

Date:Feb 18, 2016 - Feb 18, 2017

Return:-26.70%

The most profitable trade made by Christopher Leamon

See the Latest Stocks Traded by Insiders

Christopher Leamon's Trading History

ECYT

Endocyte

Dec 21, 2018

―

Uninformative Sell

3.94M

$0.00

FUSN

Fusion Pharmaceuticals

Jan 05, 2024

CSO

Uninformative Buy

―

$255.88K

List of latest transactions for each holding click on a transaction to see Christopher Leamon's performance on stock

See All Insider Trading from Today

Christopher Leamon insider profile FAQ

What is the percentage of profitable transactions made by Christopher Leamon?

The percentage of profitable transactions made by Christopher Leamon is 0%.

What is the average return per transaction made by Christopher Leamon?

The average return per transaction made by Christopher Leamon is -37.50%.

What stocks does Christopher Leamon hold?

Christopher Leamon holds: ECYT, FUSN stocks.

What was Christopher Leamon’s latest transaction?

Christopher Leamon latest transaction was an Uninformative Buy of ―.

What was Christopher Leamon's most profitable transaction?

Christopher Leamon’s most profitable transaction was an Informative Buy of ECYT stock on February 18, 2016. The return on the trade was -26.70%.

What is Christopher Leamon's role in Endocyte?

Christopher Leamon's role in Endocyte is VP of Research.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Christopher Leamon Insider Profile

Christopher Leamon Endocyte (ECYT)VP of Research